Hayat Nasser
(Addis Continental Institute of Public Health, 2023-05)
Background: Since 2019, Dolutegravir has been introduced as a first line therapy and many newly
diagnosed HIV patients and patients on other Antiretrovirals are being started on this medication.
Dolutegravir based ...